RSV

18 registered clinical trials studyying RSV — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	RSV Vaccination to Reduce Recurrent AECOPD NCT07508644	Chinese University of Hong Kong	Phase 4
Not Yet Recruiting	A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Mon NCT07482657	Enanta Pharmaceuticals, Inc	Phase 2
Not Yet Recruiting	Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine NCT07418229	Sinovac Biotech Co., Ltd	Phase 1
Not Yet Recruiting	RSV Burden in Hong Kong NCT07321314	Chinese University of Hong Kong	—
Not Yet Recruiting	Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Se NCT07217639	Aptitude Medical Systems	N/A
Recruiting	Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy NCT07097012	Canadian Immunization Research Network	Phase 4
Recruiting	Preparedness Through Respiratory Virus Epidemiology and Community Engagement NCT07147517	University of California, San Diego	—
Recruiting	SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGA NCT07030075	Centre for Infectious Disease Research in Zambia	—
Recruiting	Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations NCT06684743	Tor Biering-Sørensen	Phase 4
Completed	Covid Flu A/B and RSV 4 in 1 Diagnostic Test NCT07308158	iHealth Labs inc	—
Completed	Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay NCT06689423	Credo Diagnostics Biomedical Pte. Ltd.	—
Recruiting	A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients NCT06672692	DiaSorin Molecular LLC	N/A
Recruiting	Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL) NCT06511687	Instituto Sistemas Complejos de Ingeniería	—
Completed	A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RS NCT05585632	ModernaTX, Inc.	Phase 1
Recruiting	Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA) NCT06160128	VA Office of Research and Development	—
Completed	Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age NCT05096208	Pfizer	Phase 3
Completed	Adherence to Palivizumab Prophylaxis NCT05778240	Kosuyolu Heart Hospital	N/A
Unknown	The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate. NCT01985620	Tel-Aviv Sourasky Medical Center	N/A